<SEC-DOCUMENT>0001140361-25-002203.txt : 20250128
<SEC-HEADER>0001140361-25-002203.hdr.sgml : 20250128
<ACCEPTANCE-DATETIME>20250128163035
ACCESSION NUMBER:		0001140361-25-002203
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250128
DATE AS OF CHANGE:		20250128

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celularity Inc
		CENTRAL INDEX KEY:			0001752828
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				831702591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91021
		FILM NUMBER:		25564655

	BUSINESS ADDRESS:	
		STREET 1:		170 PARK AVE
		CITY:			FLORHAM PARK
		STATE:			NJ
		ZIP:			07932
		BUSINESS PHONE:		(908) 768-2170

	MAIL ADDRESS:	
		STREET 1:		170 PARK AVE
		CITY:			FLORHAM PARK
		STATE:			NJ
		ZIP:			07932

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GX Acquisition Corp.
		DATE OF NAME CHANGE:	20180912

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dragasac Ltd
		CENTRAL INDEX KEY:			0001872884
		ORGANIZATION NAME:           	
		IRS NUMBER:				981594646
		STATE OF INCORPORATION:			Y8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O 24TH FLOOR, WISMA GENTING
		STREET 2:		JALAN SULTAN ISMAIL
		CITY:			KUALA  LUMPUR
		STATE:			N8
		ZIP:			50250
		BUSINESS PHONE:		603 2333 6888

	MAIL ADDRESS:	
		STREET 1:		C/O 24TH FLOOR, WISMA GENTING
		STREET 2:		JALAN SULTAN ISMAIL
		CITY:			KUALA  LUMPUR
		STATE:			N8
		ZIP:			50250
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<previousAccessionNumber>0001140361-21-025617</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001872884</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>5</amendmentNo>
<securitiesClassTitle>Class A Common Stock, par value $0.0001 per share</securitiesClassTitle>
<dateOfEvent>01/24/2025</dateOfEvent>
<previouslyFiledFlag>false</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001752828</issuerCIK>
<issuerCUSIP>151190204</issuerCUSIP>
<issuerName>Celularity Inc</issuerName>
<address>
<com:street1>170 PARK AVE</com:street1>
<com:city>FLORHAM PARK</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>07932</com:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>c/o Tan Kong Han</personName>
<personPhoneNum>(603) 2333-6888</personPhoneNum>
<personAddress>
<com:street1>Dragasac Ltd., 25th Floor, Wisma Genting</com:street1>
<com:street2>Jalan Sultan Ismail, Kuala Lumpur,</com:street2>
<com:city>Wilayah Persekutuan</com:city>
<com:stateOrCountry>N8</com:stateOrCountry>
<com:zipCode>50250</com:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001872884</reportingPersonCIK>
<reportingPersonName>Dragasac Ltd</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>AF</fundType>
<citizenshipOrOrganization>Y8</citizenshipOrOrganization>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>6335630</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>6335630</sharedDispositivePower>
<aggregateAmountOwned>6335630</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>26.8</percentOfClass>
<typeOfReportingPerson>OO</typeOfReportingPerson>
<commentContent>Percent of class represented by amount in Row (11) is based on the sum of (i) 22,484,239 Common Shares outstanding as of December 2, 2024, based on information reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the Commission on December 6, 2024, (ii) 652,981 Common Shares issued to the Reporting Person upon exercise of the Second Amended Dragasac Warrants (as defined herein), and (iii) 535,274 Common Shares issued to the Reporting Person upon exercise of the Amended New Dragasac Warrants (as defined herein).</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>Resorts World Inc Pte. Ltd.</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>AF</fundType>
<fundType>WC</fundType>
<citizenshipOrOrganization>U0</citizenshipOrOrganization>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>3600000</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>3600000</sharedDispositivePower>
<aggregateAmountOwned>3600000</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>13.2</percentOfClass>
<typeOfReportingPerson>OO</typeOfReportingPerson>
<commentContent>1. Shared voting and dispositive power and the aggregate amount beneficially owned by the Reporting Person includes 3,600,000 Common Shares that the Reporting Person has the right to acquire upon exercise of warrants.&#13;
2. Percent of class represented by amount in Row (11) is based on the sum of (i) 22,484,239 Common Shares outstanding as of December 2, 2024, based on information reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the Commission on December 6, 2024, (ii) 652,981 Common Shares issued to Dragasac upon exercise of the Second Amended Dragasac Warrants, and (iii) 535,274 Common Shares issued to Dragasac upon exercise of the Amended New Dragasac Warrants, plus (iv) 3,600,000 Common Shares issuable to the Reporting Person upon exercise of warrants, with (iv) having been added to the Common Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act.</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>Genting Berhad</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>WC</fundType>
<citizenshipOrOrganization>N8</citizenshipOrOrganization>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>9935630</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>9935630</sharedDispositivePower>
<aggregateAmountOwned>9935630</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>36.4</percentOfClass>
<typeOfReportingPerson>HC</typeOfReportingPerson>
<typeOfReportingPerson>OO</typeOfReportingPerson>
<commentContent>1. Shared voting and dispositive power and the aggregate amount beneficially owned by the Reporting Person includes 3,600,000 Common Shares that RWI has the right to acquire upon exercise of warrants.&#13;
2. Percent of class represented by amount in Row (11) is based on the sum of (i) 22,484,239 Common Shares outstanding as of December 2, 2024, based on information reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the Commission on December 6, 2024, (ii) 652,981 Common Shares issued to Dragasac upon exercise of the Second Amended Dragasac Warrants, and (iii) 535,274 Common Shares issued to Dragasac upon exercise of the Amended New Dragasac Warrants, plus (iv) 3,600,000 Common Shares issuable to RWI upon exercise of warrants, with (iv) having been added to the Common Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act.</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>Lim Kok Thay</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>AF</fundType>
<citizenshipOrOrganization>N8</citizenshipOrOrganization>
<soleVotingPower>2531</soleVotingPower>
<sharedVotingPower>9935630</sharedVotingPower>
<soleDispositivePower>2531</soleDispositivePower>
<sharedDispositivePower>9935630</sharedDispositivePower>
<aggregateAmountOwned>9938161</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>36.4</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<typeOfReportingPerson>HC</typeOfReportingPerson>
<commentContent>1. Shared voting and dispositive power and the aggregate amount beneficially owned by the Reporting Person includes 3,600,000 Common Shares that RWI has the right to acquire upon exercise of warrants.&#13;
2. Percent of class represented by amount in Row (11) is based on the sum of (i) 22,484,239 Common Shares outstanding as of December 2, 2024, based on information reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the Commission on December 6, 2024, (ii) 652,981 Common Shares issued to Dragasac upon exercise of the Second Amended Dragasac Warrants, and (iii) 535,274 Common Shares issued to Dragasac upon exercise of the Amended New Dragasac Warrants, plus (iv) 3,600,000 Common Shares issuable to RWI upon exercise of warrants, with (iv) having been added to the Common Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act.</commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Class A Common Stock, par value $0.0001 per share</securityTitle>
<issuerName>Celularity Inc</issuerName>
<issuerPrincipalAddress>
<com:street1>170 PARK AVE</com:street1>
<com:city>FLORHAM PARK</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>07932</com:zipCode>
</issuerPrincipalAddress>
<commentText>Pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended, this Amendment No. 5 to the Schedule 13D ("Amendment No. 5") amends certain items of the Schedule 13D filed with the Commission on July 26, 2021 (the "Original Schedule 13D"), as amended and supplemented by Amendment No. 1 filed with the Commission on June 22, 2023, Amendment No. 2 filed with the Commission on January 17, 2024, Amendment No. 3 filed with the Commission on March 15, 2024, and Amendment No. 4 filed with the Commission on December 19, 2024 (collectively, the "Schedule 13D"), relating to the Class A Common Stock, par value $0.0001 per share (the "Common Shares"), of Celularity, Inc. (the "Issuer"). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.</commentText>
</item1>
<item3>
<fundsSource>Item 3 of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
On January 24, 2025, the Issuer amended and restated the terms of each of the Amended Dragasac Warrants to purchase up to 652,981 Common Shares (as adjusted for the Reverse Stock Split (as defined in Amendment No. 3), such amended and restated warrants being the "Second Amended Dragasac Warrants") and the New Dragasac Warrants to purchase up to 535,274 Common Shares (as adjusted for the Reverse Stock Split, such amended and restated warrants being the "Amended New Dragasac Warrants") in order to adjust the exercise price of each from $2.4898 per Common Share to $2.07 per Common Share, which represents a 10% discount from the closing price of the Issuer's Common Shares on January 23, 2025.  The foregoing summary of each of the Second Amended Dragasac Warrants and Amended New Dragasac Warrants does not purport to be complete and is qualified in its entirety by reference to the full text of each of the Second Amended Dragasac Warrants and Amended New Dragasac Warrants, each of which is attached hereto as an exhibit to this Amendment No. 5 and is incorporated by reference.&#13;
&#13;
On January 24, 2025, Dragasac elected to exercise, on a cash basis, the Second Amended Dragasac Warrants and Amended New Dragasac Warrants in full, and thereby acquired an aggregate 1,188,255 Common Shares from the Issuer for an aggregate purchase price of $2,459,687.85.</fundsSource>
</item3>
<item4>
<transactionPurpose>Item 4 of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
The response to Item 3 of this Amendment No. 5 is incorporated by reference herein.</transactionPurpose>
</item4>
<item5>
<percentageOfClassSecurities>Item 5(a) of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
As of the date hereof, Dragasac may be deemed to beneficially own 6,335,630 Common Shares, or approximately 26.8% of the Common Shares outstanding.&#13;
&#13;
As of the date hereof, RWI may be deemed to beneficially own 3,600,000 Common Shares, or approximately 13.2% of the Common Shares outstanding, which consists entirely of Common Shares that RWI has the right to acquire upon exercise of warrants.&#13;
&#13;
As of the date hereof, Genting Berhad may be deemed to beneficially own 9,935,630 Common Shares, or approximately 36.4% of the Common Shares outstanding. This amount includes (i) 6,335,630 Common Shares held directly by Dragasac and (ii) 3,600,000 Common Shares that RWI has the right to acquire upon exercise of warrants. &#13;
&#13;
As of the date hereof, Mr. Lim may be deemed to beneficially own 9,938,161 Common Shares, or approximately 36.4% of the Common Shares outstanding. This amount includes (i) 6,335,630 Common Shares held directly by Dragasac, (ii) 3,600,000 Common Shares that RWI has the right to acquire upon exercise of warrants, and (iii) 2,531 Common Shares held directly by Mr. Lim.&#13;
&#13;
The percentages set forth herein are based on the sum of (i) 22,484,239 Common Shares outstanding as of December 2, 2024, based on information reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the Commission on December 6, 2024, (ii) 652,981 Common Shares issued to Dragasac upon exercise of the Second Amended Dragasac Warrants, and (iii) 535,274 Common Shares issued to Dragasac upon exercise of the Amended New Dragasac Warrants, plus, for RWI, Genting Berhad, and Mr. Lim, (iv) the 3,600,000 Common Shares issuable to RWI within sixty days upon exercise of warrants, with (iv) having been added to the Common Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act.</percentageOfClassSecurities>
<numberOfShares>Item 5(b) of the Schedule 13D is hereby amended and supplemented as follows: &#13;
&#13;
Dragasac, Genting Berhad, and Mr. Lim may be deemed to share the power to vote or direct the vote and the power to dispose or direct the disposition of, the 6,335,630 Common Shares held directly by Dragasac. RWI, Genting Berhad, and Mr. Lim may be deemed to share the power to vote or direct the vote and the power to dispose or direct the disposition of, the 3,600,000 Common Shares that RWI has the right to acquire upon exercise of warrants. Mr. Lim may be deemed to have the sole power to vote or direct the vote, and the sole power to dispose or direct the disposition of, the 2,531 Common Shares held directly by Mr. Lim.</numberOfShares>
<transactionDesc>Item 5(c) of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
The response to Item 3 of this Amendment No. 5 is incorporated by reference herein.&#13;
&#13;
Other than as disclosed herein, the Reporting Persons have not effected any transactions in the Common Shares since the filing of Amendment No. 4.</transactionDesc>
</item5>
<item6>
<contractDescription>Item 6 of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
The response to Item 3 of this Amendment No. 5 is incorporated by reference herein.&#13;
&#13;
Except as otherwise set forth in the Schedule 13D, as amended by this Amendment No. 5, there are no contracts, arrangements, understandings, or relationships between the Reporting Persons named in Item 2 and any other person with respect to any securities of the Issuer, including but not limited to transfer or voting of any such securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
</item6>
<item7>
<filedExhibits>Item 7 of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
Exhibit 99.20 Second Amended Dragasac Warrants, dated January 24, 2025.&#13;
&#13;
Exhibit 99.21 Amended New Dragasac Warrants, dated January 24, 2025.</filedExhibits>
</item7>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Dragasac Ltd</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Tan Kong Han</signature>
<title>Tan Kong Han / Director</title>
<date>01/28/2025</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Resorts World Inc Pte. Ltd.</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Hiu Woon Yau</signature>
<title>Hiu Woon Yau / Director</title>
<date>01/28/2025</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Genting Berhad</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Loh Bee Hong, Elaine</signature>
<title>Loh Bee Hong, Elaine / Corporate Secretary</title>
<date>01/28/2025</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Lim Kok Thay</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Lim Kok Thay</signature>
<title>Lim Kok Thay</title>
<date>01/28/2025</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.20
<SEQUENCE>2
<FILENAME>ef20042289_ex99-20.htm
<DESCRIPTION>EXHIBIT 99.20
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <div>
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.20</font><br>
      </div>
      <div style="text-align: justify; font-size: 12pt;"> <br>
      </div>
      <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt;">THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;ACT&#8221;), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR
          HYPOTHECATED UNLESS (A) THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, AND APPLICABLE STATE SECURITIES LAWS, COVERING ANY SUCH TRANSACTION INVOLVING SAID SECURITIES, (B) THE COMPANY RECEIVES AN OPINION OF LEGAL COUNSEL FOR THE HOLDER
          OF THESE SECURITIES SATISFACTORY TO THE COMPANY STATING THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION, OR (C) THE COMPANY OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION<font style="font-weight: bold;">.</font></font></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">SECOND AMENDED AND RESTATED WARRANT TO PURCHASE CLASS A COMMON STOCK OF CELULARITY INC.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div>Warrant Shares: 652,981</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right;">Date of Issuance: January 9, 2020</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right;">Amended and Restated Date: January 16, 2024</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right;">Second Amended and Restated Date: January 24, 2025</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">For value received, Celularity Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), hereby grants to Dragasac Limited, a company incorporated in the Isle of Man (&#8220;<font style="font-weight: bold; font-style: italic;">Holder</font>&#8221;) this warrant to purchase that number of shares of the Company&#8217;s Class A Common Stock (defined below) as set forth in <u>Section 2.2</u> hereof, as may be adjusted from time to time
        pursuant to <u>Section 12</u> hereof. This Second Amended and Restated Warrant, supersedes, amends and restates, in its entirety, the Amended and Restated Warrant to Purchase Series B Preferred Stock of Celularity Inc. (dated January 16, 2024).</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Definitions</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Business Day</font>&#8221; shall mean any day other than a Saturday, a Sunday or any other day on which the Federal Reserve Bank of New York is
        required by law to be closed.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Class A Common Stock</font>&#8221; shall mean the Class A Common Stock, par value $0.0001 per share, of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Date of Issuance</font>&#8221;<font style="color: rgb(0, 0, 0);"> means the date of issuance first written above.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Trading Day</font>&#8221; means a day on which the principal Trading Market is open for trading.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Trading Market</font>&#8221; means any of the following markets or exchanges on which the Class A Common Stock is listed or quoted for trading on the
        date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American or the New York Stock Exchange (or any successors to any of the foregoing).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (i) if the Class A Common Stock is
        then listed or quoted on a Trading Market, the daily volume weighted average price of the Class A Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Class A Common Stock is then listed or quoted as
        reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)); (ii) if the Class A Common Stock is not then listed or quoted on a Trading Market, but is listed or quoted on OTCQB or OTCQX,
        the volume weighted average price of the Class A Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX, as applicable; (iii) if the Class A Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
        for the Class A Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Class A Common Stock so reported; or (iv) in
        all other cases, the fair market value of a share of Class A Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the
        Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Warrant</font>&#8221; as used herein shall include this amended and restated warrant (as the same may be amended from time to time) and any warrants
        delivered in substitution or exchange therefor as provided herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Exercise Amount and Price</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The exercise price per share (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Exercise Price</font><font style="color: rgb(0, 0, 0);">&#8221;) at which this Warrant will be exercised shall be $2.07.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">This Warrant is exercisable for the purchase of 652,981 shares of Class A Common Stock (as such number may
          be adjusted from time to time pursuant to <u>Section 12</u> hereof).</font></div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;"><font style="color: rgb(0, 0, 0);"><u>Term</u>.</font></font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">3.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Subject to the terms and conditions set forth herein, the Holder may exercise this Warrant, in whole or in
          part, during the term commencing on the Date of Issuance and ending at 5:00 p.m. (Eastern Time) on the 60-month anniversary of the March 16, 2025.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">4.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Exercise of Warrant</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any
          time, or from time to time, during the term hereof as described in <u>Section 3</u> above, by the surrender of this Warrant and the Notice of Exercise, attached hereto as <u>Exhibit A,</u> duly completed and executed on behalf of the Holder, at
          the principal offices of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Holder), upon payment in cash, wire transfer or by check acceptable to the Company of the Exercise Price of the
          shares to be purchased (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Shares</font><font style="color: rgb(0, 0, 0);">&#8221;).</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">In lieu of payment of the aggregate Exercise Price in the manner as specified in <u>Section 4.1</u>, but
          otherwise in accordance with the requirements of <u>Section 4.1</u>, the Holder may elect to receive the Shares equal to the value of this Warrant, or portion hereof as to which this Warrant is being exercised. Upon such exercise pursuant to
          this <u>Section 4.2</u>, the Holder shall be issued such number of fully paid and non-assessable Shares as are computed using the following formula:</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">X = Y(A-B)/A</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">where:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">X = the number of Shares to be issued to the Holder;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Y = the number of Shares with respect to which this Warrant is being exercised;</div>
      <div>&#160;</div>
      <div style="text-indent: -22.5pt; margin-left: 58.5pt;">A = the VWAP on the Trading Date immediately preceding the date of the applicable Notice of Exercise; and</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">B = the Exercise Price.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Representations and Warranties of the Company</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">The Company hereby represents and warrants to Holder that the following representations and warranties are
          true and correct:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Organization, Good Standing and Qualification</u>. The Company is a corporation duly organized, validly
          existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. The Company is duly qualified to transact
          business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Authorization</u>. All corporate action on the part of the Company, its officers, directors and
          stockholders necessary for the authorization, execution and delivery of this Warrant, the performance of all obligations of the Company hereunder and thereunder, and the reservation for issuance, sale and delivery of the Class A Common Stock to
          be issued upon exercise of this Warrant has been taken. This Warrant constitutes the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable
          bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or
          other equitable remedies.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Valid Issuance of Common Stock</u>. The Class A Common Stock for which the Warrant is exercisable, when
          issued, sold and delivered in accordance with the terms of this Warrant for the consideration expressed herein, will be duly and validly issued, fully paid, and nonassessable, and will be free of restrictions on transfer other than restrictions
          on transfer under this Warrant and under applicable state and federal securities laws or liens or encumbrances created by or imposed by Holder.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Governmental Consents</u>. No consent, approval, order or authorization of, or registration,
          qualification, designation, declaration or filing with, any federal, state or local governmental authority on the part of the Company is required in connection with the issuance or exercise of this Warrant, except for (i) such federal and state
          securities filings as may be necessary, which filings will be timely effected after the date hereof and (ii) such other approval that has been obtained prior to the date hereof.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Reliance by Holder</u>. The Company understands that the representations, warranties, covenants and
          acknowledgements set forth in this <u>Section 5</u> constitute a material inducement to Holder entering into this Warrant.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Representations and Warranties of Holder</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">Holder hereby represents and warrants to the Company that the following representations and warranties are
          true and correct:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Purchase Entirely for Own Account</u>. This Warrant is being entered into for investment for Holder&#8217;s
          own account not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and Holder has no present intention of selling, granting any participation in, or otherwise distributing the same. The acquisition by
          Holder of this Warrant shall constitute confirmation of the representation by Holder that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participations to such person or to any
          third person, with respect to this Warrant.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Investment Experience</u>. Holder is an investor in securities of companies in the development stage and
          acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of entering into this
          Warrant. Holder acknowledges that the acquisition of shares of Class A Common Stock pursuant to this Warrant involves a high degree of risk, and represents that it is able, without materially impairing its financial condition, to hold such shares
          for an indefinite period of time and to suffer a complete loss of its investment. Holder acknowledges that the Company has not made any representations or warranties as to whether the Exercise Price to be paid by Holder for the Class A Common
          Stock is a fair value for such shares and the Company takes no position with respect to the fairness of the Exercise Price or the future prospects and valuation of the Company. Holder is aware of the fact that the value of the Class A Common
          Stock to be purchased upon exercise of this Warrant may significantly depreciate over time and there can be no assurances that the value of such shares will increase or to what extent. In connection with making an investment decision in
          connection with entering into this Warrant, Holder will be relying on its own knowledge and experience and advice obtained from Holder&#8217;s legal, tax and financial advisor.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Accredited Investor</u>. Holder is an &#8220;accredited investor&#8221; within the meaning of SEC Rule 501 of
          Regulation D, as presently in effect.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Legends</u>. It is understood that the certificates, if any, evidencing the shares of Class A Common
          Stock issuable upon exercise of this Warrant may bear any of the legends required by applicable state securities laws.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Reliance by Company</u>. Holder understands that the representations, warranties, covenants and
          acknowledgements set forth in this <u>Section 6</u> constitute a material inducement to the Company entering into this Warrant.</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Foreign Investors</u>. Holder hereby represents that it has satisfied itself as to the full observance of
          the laws of its jurisdiction in connection with entering into this Warrant, including (i) the legal requirements within its jurisdiction for entering into this Warrant and the exercise of this Warrant, (ii) any foreign exchange restrictions
          applicable to the exercise of this Warrant, (iii) any governmental or other consents that may need to be obtained, including with respect to the payment of the Exercise Price, and (iv) the income tax and other tax consequences, if any, that may
          be relevant to the purchase, holding, redemption, sale or transfer of this Warrant or the shares of Class A Common Stock issuable upon exercise hereof. The Holder&#8217;s acquisition of this Warrant and payment for the Class A Common Stock upon
          exercise of this Warrant and continued beneficial ownership of such shares will not violate any applicable securities or other laws of the Holder&#8217;s jurisdiction.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);"><font style="font-weight: bold; color: rgb(1, 0, 0);">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>No Fractional Shares</u></font><font style="color: rgb(0, 0, 0);">.
        </font>No fractional share of any class or series of the Company&#8217;s capital stock shall be issued upon exercise of this Warrant.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Replacement of Warrant</u></font><font style="color: rgb(0, 0, 0);">. On receipt of
          evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and (a) in the case of loss, theft, or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance
          to the Company or (b) in the case of mutilation, on surrender and cancellation of this Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. The Holder shall reimburse the Company for all
          reasonable expenses incidental to replacement of this Warrant.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Rights of Stockholder</u></font><font style="color: rgb(0, 0, 0);">. This Warrant
          shall not entitle its holder to any of the rights of a stockholder of the Company until this Warrant shall have been exercised and the shares of Class A Common Stock purchasable upon the exercise hereof shall have been issued.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Notice of Certain Events</u></font><font style="color: rgb(0, 0, 0);">.</font><font style="font-weight: bold; color: rgb(0, 0, 0);">&#160;</font><font style="color: rgb(0, 0, 0);">Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to <u>Section 12</u> hereof and if so requested by
          Holder, the Company shall issue a certificate signed by its Chief Financial Officer, or other similar officer, setting forth in reasonable detail the event requiring the adjustment, the amount of the adjustment, the method by which such
          adjustment was calculated and the Exercise Price and number of shares purchasable hereunder after giving effect to such adjustment and shall cause a copy of such certificate to be mailed (by first class mail, postage prepaid) to the Holder of
          this Warrant.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Amendments; Waivers</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">11.1</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Amendments</u></font><font style="color: rgb(0, 0, 0);">. The provisions of this Warrant
          may be amended (either generally or in a particular instance and either retroactively or prospectively), only by an instrument in writing signed by the Company and the Holder. The foregoing shall not limit or otherwise affect Holder&#8217;s right to
          waive any of such Holder&#8217;s rights hereunder. Any amendment or waiver effected in accordance with this <u>Section 11.1</u> shall be binding upon Holder and Holder&#8217;s successors and assigns.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">11.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Waivers</u></font><font style="color: rgb(0, 0, 0);">. No waivers of or exceptions to
          any term, condition or provision of this Warrant, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition or provision.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Adjustments</u></font><font style="color: rgb(0, 0, 0);">. The Exercise Price and the
          number and type of shares purchasable hereunder are subject to adjustment from time to time as follows:</font></div>
      <div>&#160;</div>
      <div style="color: rgb(0, 0, 0); text-indent: 36pt; text-align: justify;"><font style="color: rgb(1, 0, 0);">12.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Reclassification, etc</u></font><font style="color: rgb(0, 0, 0);">.</font> If, at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the Company shall, by reclassification of securities or otherwise, change any of the securities as to which purchase rights under
        this Warrant exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such
        change with respect to the securities which were subject to the purchase rights under this Warrant immediately prior to such reclassification or other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further
        adjustment as provided in this <u>Section 12</u>; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that the aggregate Exercise Price shall remain the same.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="color: rgb(0, 0, 0); text-indent: 36pt; text-align: justify;"><font style="color: rgb(1, 0, 0);">12.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Split, Subdivision or Combination of Shares</u></font><font style="color: rgb(0, 0, 0);">.</font> If at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the Company shall split, subdivide or combine the securities as to which purchase rights under this Warrant
        exist into a different number of securities of the same class, the Exercise Price for such securities shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination. Upon an
        adjustment in the Exercise Price pursuant to this <u>Section 12.2</u>, the number of shares subject to this Warrant (which were the subject of such split, subdivision or combination) shall be adjusted accordingly such that the aggregate Exercise
        Price payable for the purchase of such shares shall remain the same as before such split, subdivision or combination.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="color: rgb(0, 0, 0); text-indent: 36pt; text-align: justify;"><font style="color: rgb(1, 0, 0);">12.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Adjustments for Dividends in Stock or Other Securities or
            Property</u></font><font style="color: rgb(0, 0, 0);">. </font>If at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the holders of the securities as to which purchase rights under this Warrant
        exist at the time shall have received, or on or after the record date fixed for the determination of eligible stockholders shall have become entitled to receive, without payment therefor, other or additional stock or other securities or property
        (other than cash) of the Company by way of dividend or other distribution in respect of the Class A Common Stock, then, and in each case, this Warrant shall represent the right to acquire, in addition to the number of shares of the security
        receivable upon exercise of this Warrant and without payment of any additional consideration therefor, the amount of such other or additional stock or other securities or property (other than cash) of the Company which such holder would hold on the
        date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period from the date hereof to and including the date of such exercise, retained such
        shares and/or all other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions of this <u>Section 12</u>, and, from and after the date of such
        distribution, the Company shall hold and set aside (or cause to be held and set aside in a commercially reasonable manner) an amount of such property equal to Holder&#8217;s pro rata portion thereof for distribution to Holder pursuant hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">13.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Reservation of Capital Stock</u></font><font style="color: rgb(0, 0, 0);">.</font><font style="font-weight: bold; color: rgb(0, 0, 0);">&#160;</font><font style="color: rgb(0, 0, 0);">The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Class A Common Stock that shall be sufficient
          to permit the exercise in full of all outstanding warrants issued pursuant to this Warrant.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Miscellaneous</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.1</font>&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Survival of Representations, Warranties and Covenants</u>. The warranties, representations and covenants of
          each party hereto contained in or made pursuant to this Warrant shall survive the execution and delivery of this Warrant and shall in no way be affected by any investigation of the subject matter thereof made by or on behalf of the Holder or the
          Company, as applicable.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Titles and Subtitles</u>. The titles and subtitles used in this Warrant are used for convenience only and
          are not to be considered in construing or interpreting this Warrant.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.3</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Governing Law</u>. This Warrant is to be construed in accordance with and governed by the internal laws of
          the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties. All disputes and
          controversies arising out of or in connection with this Warrant shall be resolved exclusively by the state or federal courts located within the City of Wilmington in the State of Delaware, and each party hereto agrees to submit to the
          jurisdiction of said courts and agrees that venue shall lie exclusively with such courts.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.4</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Waiver of Right to Jury Trial</u>. EACH OF HOLDER AND THE COMPANY, TO THE FULLEST EXTENT PERMITTED BY
          APPLICABLE LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS WARRANT.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.5</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Notices</u>. Except as may be otherwise provided herein, all notices, requests, waivers and other
          communications made pursuant to this Warrant shall be in writing and shall be conclusively deemed to have been duly given (i) when hand delivered to the other party; (ii) when sent by email or facsimile if sent between 8:00 a.m. and 5:00 p.m.
          recipient&#8217;s local time on a Business Day, or on the next Business Day if sent by email or facsimile other than between 8:00 a.m. and 5:00 p.m. recipient&#8217;s local time on a Business Day; (iii) seven Business Days after deposit in the U.S. mail with
          first class or certified mail receipt requested postage prepaid and addressed to the other party; or (iv) the next Business Day after deposit with an international overnight delivery service, postage prepaid, addressed to the parties with next
          Business Day delivery guaranteed, provided that the sending party receives a confirmation of delivery from the delivery service provider. Each person making a communication hereunder by email or facsimile shall promptly confirm by telephone
          between 8:00 a.m. and 5:00 p.m. recipient&#8217;s local time on a Business Day to the person to whom such communication was addressed each communication made by it by email or facsimile pursuant hereto but the absence of such confirmation shall not
          affect the validity of any such communication. All communications shall be sent to the address, email address or facsimile number of a party appearing in its signature block hereto or at such address, email address or facsimile number as such
          party may designate by ten (10) days advance written notice to the other parties hereto.</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.6</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Specific Performance</u>. Each party hereto acknowledges and agrees that any breach of this Warrant would
          result in substantial harm to the other party hereto for which monetary damages alone could not adequately compensate. Therefore, the parties hereto unconditionally and irrevocably agree that any non-breaching party hereto shall be entitled to
          seek protective orders, injunctive relief and other remedies available at law or in equity (including, without limitation, seeking specific performance).</font></div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">14.7</font>&#160;&#160;&#160;&#160;&#160;&#160;<u></u><font style="color: rgb(0, 0, 0);"><u>Counterparts</u>. This Warrant may be executed and delivered by facsimile signature and in two or
          more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature
          complying with the U.S. federal ESIGN Act of 2000, e.g.www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font></div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0);">[<font style="font-style: italic;">Remainder of Page Intentionally Left Blank</font>]</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the Company has caused this Warrant to be executed by its duly
          authorized officer as of the Date of Issuance indicated above.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z81da4e5f4b2149479b031cfd5ce8730d">

          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;"><u>COMPANY</u>:</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">CELULARITY INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;/s/ Robert J. Hariri</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;">
              <div>Name: Robert J. Hariri</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;">
              <div>Title: CEO</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>HOLDER</u></font><font style="font-size: 10pt;">:</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">DRAGASAC LIMITED</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;">
              <div>Name:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;">
              <div>Title:</div>
            </td>
          </tr>

      </table>
      <div>
        <div style="text-align: center; font-size: 8pt;"> <br>
        </div>
        <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to A&amp;R Warrant &#8211; Dragasac Limited</font>]</div>
        <div style="text-align: center; font-size: 8pt;"> <br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the Company has caused this Warrant to be executed by its duly
          authorized officer as of the Amended and Restated Date indicated above.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z309846b4ea934f609513125ba2ed42c8">

          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;"><u>COMPANY</u>:</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">CELULARITY INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div>Name: Robert J. Hariri</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div>Title: CEO</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>HOLDER</u></font><font style="font-size: 10pt;">:</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">DRAGASAC LIMITED</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Tan Kong Han</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div>Name: <u>Tan</u> Kong Han</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div>Title: Director</div>
            </td>
          </tr>

      </table>
      <div>
        <div style="text-align: center;"> <br>
        </div>
        <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to A&amp;R Warrant &#8211; Dragasac Limited</font>]<br>
          <br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-variant: small-caps; font-weight: bold;">Notice of Exercise</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>To:&#160; Celularity Inc.</div>
      <div style="margin-left: 18pt;">170 Park Ave</div>
      <div style="margin-left: 18pt;">Florham Park, New Jersey 07932</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">By checking the appropriate line, the undersigned (&#8220;<font style="font-weight: bold; font-style: italic;">Holder</font>&#8221;), pursuant to the provisions set forth in the Second Amended and Restated
        Warrant to Purchase Class A Common Stock, dated January [&#160; &#160; ], 2025 (the &#8220;<font style="font-weight: bold; font-style: italic;">Warrant</font>&#8221;), hereby elects to purchase 652,981 shares of Class A Common Stock (as defined in the Warrant) pursuant
        to the terms of the Warrant, and tenders herewith payment of the purchase price for such shares in full as follows:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f41513551fa42c1bc3357c7c713aae8">

          <tr>
            <td style="width: 36pt; vertical-align: top;">&#9744;</td>
            <td style="width: auto; vertical-align: top;">
              <div>check in the amount of $_______________ payable to order of the Company enclosed herewith</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze801f52fdd7a4623a70fbe2b012b2bc9">

          <tr>
            <td style="width: 36pt; vertical-align: top;">&#9744;</td>
            <td style="width: auto; vertical-align: top;">
              <div>wire transfer of immediately available funds to the Company&#8217;s bank account</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3d5e546e3c14f7db1c6ceeb957bd22b">

          <tr>
            <td style="width: 36pt; vertical-align: top;">&#9744;</td>
            <td style="width: auto; vertical-align: top;">
              <div>cashless exercise pursuant to <u>Section 4.2</u> of the Warrant</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z957ba9f168ca41379ea94e7348018f6c">

          <tr>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 23%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Date:</div>
            </td>
            <td style="width: 52.36%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 52.36%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top;">
              <div>DRAGASAC LIMITED, <u>TAN</u> KONG HAN (DIRECTOR)</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top;">
              <div>(Print Name)</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 52.36%; vertical-align: top;">
              <div>Signature</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.21
<SEQUENCE>3
<FILENAME>ef20042289_ex99-21.htm
<DESCRIPTION>EXHIBIT 99.21
<TEXT>
<html style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
  <head>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <hr noshade="noshade" align="center" style="height: 4px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;">
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;"> Exhibit 99.21</font><font style="font-size: 10pt;"><br>
    </font></div>
  <div> <font style="font-size: 10pt;"><br>
    </font></div>
  <div>
    <div style="text-align: justify; font-size: 10pt;">NEITHER THE ISSUANCE OF THIS SECURITY NOR THE ISSUANCE OF THE SECURITIES INTO WHICH IT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND,
      ACCORDINGLY, NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH IT IS EXERCISABLE MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
      NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
      ACCOUNT WITH A REGISTERED BROKER-DEALER&#160;OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-align: center; font-weight: bold;">AMENDED AND RESTATED WARRANT TO PURCHASE CLASS A COMMON STOCK OF CELULARITY INC.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zc4a1a6833e394631b48866e62e7bd0d5" style="width: 100%;">

        <tr>
          <td style="width: 50%; font-size: 10pt; text-align: left; vertical-align: top;">
            <div>Warrant Shares: 535,274</div>
          </td>
          <td style="width: 50%; text-align: right; vertical-align: top;">
            <div style="font-size: 10pt;">Date of Issuance: January 16, 2024</div>
            <div style="font-size: 10pt;">Amended and Restated Date: January 24, 2025</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-size: 10pt;">For value received, Celularity Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), hereby grants to Dragasac Limited, a company incorporated in the
      Isle of Man (&#8220;<font style="font-weight: bold; font-style: italic;">Holder</font>&#8221;) this warrant (&#8220;<font style="font-weight: bold; font-style: italic;">Warrant</font>&#8221;), upon the terms and subject to the limitations on exercise and the conditions
      hereinafter set forth, at any time on or after January 16, 2024 and on or prior to 5:00 p.m. (New York City time) on January 16, 2029 (the &#8220;<font style="font-weight: bold; font-style: italic;">Termination Date</font>&#8221;), but not thereafter, to
      purchase that number of shares of the Company&#8217;s Class A Common Stock (defined below) as set forth in <u>Section 2.2</u> hereof, as may be adjusted from time to time pursuant to <u>Section 12</u> hereof. The purchase price of one share of Class A
      Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.1. This Amended and Restated Warrant supersedes, amends and restates, in its entirety, the Warrant to Purchase Class A Common Stock of Celularity Inc.
      issued on January 16, 2024.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-size: 10pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Definitions</u>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<font style="font-weight: bold; font-style: italic;">Purchase Agreement</font>&#8221;), dated January 12, 2024, between the Company and the Holder.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; shall mean any day other than a Saturday, a Sunday or any other day on which the Federal Reserve Bank of New York is required
      by law to be closed.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#8220;<font style="font-weight: bold;">Class A Common Stock</font>&#8221; shall mean the Class A Common Stock, par value $0.0001 per share, of the Company.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">&#8220;<font style="font-weight: bold;">Date of Issuance</font>&#8221; means the date of issuance first written above.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">&#8220;<font style="font-weight: bold;">Trading Market</font>&#8221; means any of the following markets or exchanges on which the Class A Common Stock is listed or quoted for trading on the date
      in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American or the New York Stock Exchange (or any successors to any of the foregoing).</div>
    <div style="text-align: left; font-size: 10pt; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">&#8220;<font style="font-weight: bold;">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (i) if the Class A Common Stock is then
      listed or quoted on a Trading Market, the daily volume weighted average price of the Class A Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Class A Common Stock is then listed or quoted as reported by
      Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)); (ii) if the Class A Common Stock is not then listed or quoted on a Trading Market, but is listed or quoted on OTCQB or OTCQX, the volume
      weighted average price of the Class A Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX, as applicable; (iii) if the Class A Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
      Class A Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Class A Common Stock so reported; or (iv) in all other
      cases, the fair market value of a share of Class A Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Shares then outstanding and reasonably acceptable to the Company.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Exercise Amount and Price</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The exercise price per share (the &#8220;Exercise Price&#8221;) at which this Warrant will be exercised shall be $2.07, subject to adjustment as provided in <u>Section 12</u> hereof
      for reverse and forward stock splits, stock dividends, stock combinations and other similar transaction of the Common Stock that occur after the date of this Warrant and prior to the exercise of the Warrant or the Termination Date.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Warrant is exercisable for the purchase of 535,274 shares of Class A Common Stock (as such number may be adjusted from time to time pursuant to <u>Section 12</u>
      hereof).</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Term</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to the terms and conditions set forth herein, the Holder may exercise this Warrant, in whole or in part, during the term commencing on the Date of Issuance and ending at 5:00 p.m.
      (New York City time) on the Termination Date.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exercise of Warrant</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any time, or from time to time, during the term hereof as described
      in <u>Section 3</u> above, by the surrender of this Warrant and the Notice of Exercise, attached hereto as <u>Exhibit A</u>, duly completed and executed on behalf of the Holder, at the principal offices of the Company (or such other office or
      agency of the Company as it may designate by notice in writing to the Holder), upon payment in cash, wire transfer or by check acceptable to the Company of the Exercise Price of the shares to be purchased (the &#8220;<font style="font-weight: bold; font-style: italic;">Shares</font>&#8221;).</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; text-align: justify; font-size: 10pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In lieu of payment of the aggregate Exercise Price in the manner as specified in <u>Section 4.1</u>, but otherwise in accordance with the requirements of <u>Section
        4.1</u>, the Holder may elect to receive the Shares equal to the value of this Warrant, or portion hereof as to which this Warrant is being exercised. Upon such exercise pursuant to this <u>Section 4.2</u>, the Holder shall be issued such number
      of fully paid and non-assessable Shares as are computed using the following formula:</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">X = Y(A-B)/A</div>
    <div style="margin-left: 36pt; font-size: 10pt;">&#160;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">where:</div>
    <div style="margin-left: 36pt; font-size: 10pt;">&#160;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">X = the number of Shares to be issued to the Holder;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">&#160;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">Y = the number of Shares with respect to which this Warrant is being exercised;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <font style="font-size: 10pt;"> </font>
    <div style="margin-left: 36pt; font-size: 10pt;">A = the VWAP on the Trading Date immediately preceding the date of the applicable Notice of Exercise; and</div>
    <div style="margin-left: 36pt; font-size: 10pt;">&#160;</div>
    <div style="margin-left: 36pt; font-size: 10pt;">B = the Exercise Price.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of the Holder and upon surrender of this Warrant, at the time of delivery of the
      Shares purchased by the Holder upon the exercise pursuant to Section 4.1 or 4.2, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased shares of Class A Common Stock called for by this Warrant, which new
      Warrant shall in all other respects be identical with this Warrant.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Representations and Warranties of the Company</u>.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company hereby represents and warrants to Holder that the following representations and warranties are true and correct:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Organization, Good Standing and Qualification</u>. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of
      Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the
      failure to so qualify would have a material adverse effect on its business or properties.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorization</u>. All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization, execution and delivery
      of this Warrant, the performance of all obligations of the Company hereunder and thereunder, and the reservation for issuance, sale and delivery of the Class A Common Stock to be issued upon exercise of this Warrant has been taken. This Warrant
      constitutes the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
      application affecting enforcement of creditors&#8217; rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Valid Issuance of Common Stock</u>. The Class A Common Stock for which the Warrant is exercisable, when issued, sold and delivered in accordance with the terms of
      this Warrant for the consideration expressed herein, will be duly and validly issued, fully paid, and nonassessable, and will be free of restrictions on transfer other than restrictions on transfer under this Warrant and under applicable state and
      federal securities laws or liens or encumbrances created by or imposed by Holder.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governmental Consents</u>. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
      state or local governmental authority on the part of the Company is required in connection with the issuance or exercise of this Warrant, except for (i) such federal and state securities filings as may be necessary, which filings will be timely
      effected after the date hereof and (ii) such other approval that has been obtained prior to the date hereof.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reliance by Holder</u>. The Company understands that the representations, warranties, covenants and acknowledgements set forth in this <u>Section 5</u> constitute a
      material inducement to Holder entering into this Warrant.</div>
  </div>
  <div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="font-size: 10pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Representations and Warranties of Holder</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;">6.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Holder hereby represents and warrants to the Company that the following representations and warranties are true and correct:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Purchase Entirely for Own Account</u>. This Warrant is being entered into for investment for Holder&#8217;s own account not as a nominee or agent, and not with a view to
      the resale or distribution of any part thereof, and Holder has no present intention of selling, granting any participation in, or otherwise distributing the same. The acquisition by Holder of this Warrant shall constitute confirmation of the
      representation by Holder that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participations to such person or to any third person, with respect to this Warrant.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Investment Experience</u>. Holder is an investor in securities of companies in the development stage and acknowledges that it is able to fend for itself, can bear the
      economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of entering into this Warrant. Holder acknowledges that the acquisition of shares of Class A
      Common Stock pursuant to this Warrant involves a high degree of risk, and represents that it is able, without materially impairing its financial condition, to hold such shares for an indefinite period of time and to suffer a complete loss of its
      investment. Holder acknowledges that the Company has not made any representations or warranties as to whether the Exercise Price to be paid by Holder for the Class A Common Stock is a fair value for such shares and the Company takes no position with
      respect to the fairness of the Exercise Price or the future prospects and valuation of the Company. Holder is aware of the fact that the value of the Class A Common Stock to be purchased upon exercise of this Warrant may significantly depreciate over
      time and there can be no assurances that the value of such shares will increase or to what extent. In connection with making an investment decision in connection with entering into this Warrant, Holder will be relying on its own knowledge and
      experience and advice obtained from Holder&#8217;s legal, tax and financial advisor.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Accredited Investor</u>. Holder is an &#8220;accredited investor&#8221; within the meaning of SEC Rule 501 of Regulation D, as presently in effect.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legends</u>. It is understood that the certificates, if any, evidencing the shares of Class A Common Stock issuable upon exercise of this Warrant may bear any of the
      legends required by applicable state securities laws.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reliance by Company</u>. Holder understands that the representations, warranties, covenants and acknowledgements set forth in this <u>Section 6</u> constitute a
      material inducement to the Company entering into this Warrant.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Foreign Investors</u>. Holder hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with entering
      into this Warrant, including (i) the legal requirements within its jurisdiction for entering into this Warrant and the exercise of this Warrant, (ii) any foreign exchange restrictions applicable to the exercise of this Warrant, (iii) any governmental
      or other consents that may need to be obtained, including with respect to the payment of the Exercise Price, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale or transfer of
      this Warrant or the shares of Class A Common Stock issuable upon exercise hereof. The Holder&#8217;s acquisition of this Warrant and payment for the Class A Common Stock upon exercise of this Warrant and continued beneficial ownership of such shares will
      not violate any applicable securities or other laws of the Holder&#8217;s jurisdiction.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-align: justify;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Fractional Shares</u>.No fractional share of any class or series of the Company&#8217;s capital stock shall be issued upon exercise of this Warrant.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="font-size: 10pt; text-align: justify;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Replacement of Warrant</u>. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and (a) in the case of loss,
      theft, or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or (b) in the case of mutilation, on surrender and cancellation of this Warrant, the Company shall execute and deliver, in lieu
      of this Warrant, a new warrant of like tenor and amount. The Holder shall reimburse the Company for all reasonable expenses incidental to replacement of this Warrant.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-align: justify;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Rights of Stockholder</u>. This Warrant shall not entitle its holder to any of the rights of a stockholder of the Company until this Warrant shall have been exercised and the shares of
      Class A Common Stock purchasable upon the exercise hereof shall have been issued.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-align: justify;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice of Certain Events</u>. Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to <u>Section 12</u> hereof and if so requested by Holder,
      the Company shall issue a certificate signed by its Chief Financial Officer, or other similar officer, setting forth in reasonable detail the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was
      calculated and the Exercise Price and number of shares purchasable hereunder after giving effect to such adjustment and shall cause a copy of such certificate to be mailed (by first class mail, postage prepaid) to the Holder of this Warrant.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Amendments; Waivers</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">11.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments</u>. The provisions of this Warrant may be amended (either generally or in a particular instance and either retroactively or prospectively), only by an
      instrument in writing signed by the Company and the Holder. The foregoing shall not limit or otherwise affect Holder&#8217;s right to waive any of such Holder&#8217;s rights hereunder. Any amendment or waiver effected in accordance with this <u>Section 11.1</u>
      shall be binding upon Holder and Holder&#8217;s successors and assigns.</div>
    <div style="text-indent: 36pt; font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">11.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waivers</u>. No waivers of or exceptions to any term, condition or provision of this Warrant, in any one or more instances, shall be deemed to be or construed as a
      further or continuing waiver of any such term, condition or provision.</div>
    <div style="font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="font-size: 10pt; text-align: justify;">12.&#160;&#160;&#160;&#160;&#160;&#160; <u>Adjustments</u>. The Exercise Price and the number and type of shares purchasable hereunder are subject to adjustment from time to time as follows:</div>
    <div style="font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">12.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reclassification, etc</u>.If, at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the Company shall, by
      reclassification of securities or otherwise, change any of the securities as to which purchase rights under this Warrant exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent
      the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Warrant immediately prior to such reclassification or
      other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this <u>Section 12</u>; provided, however, that the aggregate Exercise Price shall remain the same.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">12.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Split, Subdivision or Combination of Shares</u>. If at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the Company
      shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the Exercise Price for such securities shall be proportionately decreased in the case of a
      split or subdivision or proportionately increased in the case of a combination. Upon an adjustment in the Exercise Price pursuant to this <u>Section 12.2</u>, the number of shares subject to this Warrant (which were the subject of such split,
      subdivision or combination) shall be adjusted accordingly such that the aggregate Exercise Price payable for the purchase of such shares shall remain the same as before such split, subdivision or combination.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">12.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustments for Dividends in Stock or Other Securities or Property</u>.If at any time on or after the date hereof and while this Warrant remains outstanding and
      unexpired, the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or on or after the record date fixed for the determination of eligible stockholders shall have become entitled to receive,
      without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of dividend or other distribution in respect of the Class A Common Stock, then, and in each case, this Warrant shall represent
      the right to acquire, in addition to the number of shares of the security receivable upon exercise of this Warrant and without payment of any additional consideration therefor, the amount of such other or additional stock or other securities or
      property (other than cash) of the Company which such holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period
      from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions
      of this <u>Section 12</u>, and, from and after the date of such distribution, the Company shall hold and set aside (or cause to be held and set aside in a commercially reasonable manner) an amount of such property equal to Holder&#8217;s pro rata portion
      thereof for distribution to Holder pursuant hereto.</div>
    <div style="font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="font-size: 10pt; text-align: justify;">13.&#160;&#160;&#160;&#160;&#160;&#160; <u>Reservation of Capital Stock</u>. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Class A Common Stock that shall be sufficient
      to permit the exercise in full of all outstanding warrants issued pursuant to this Warrant.</div>
    <div style="font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="font-size: 10pt; text-align: justify;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous</u>.</div>
    <div style="font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Survival of Representations, Warranties and Covenants</u>. The warranties, representations and covenants of each party hereto contained in or made pursuant to this
      Warrant shall survive the execution and delivery of this Warrant and shall in no way be affected by any investigation of the subject matter thereof made by or on behalf of the Holder or the Company, as applicable.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Titles and Subtitles</u>. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing or interpreting this
      Warrant.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>. This Warrant is to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice
      of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties. All disputes and controversies arising out of or in connection with this
      Warrant shall be resolved exclusively by the state or federal courts located within the City of Wilmington in the State of Delaware, and each party hereto agrees to submit to the jurisdiction of said courts and agrees that venue shall lie exclusively
      with such courts.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Right to Jury Trial</u>. EACH OF HOLDER AND THE COMPANY, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY
      JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS WARRANT.</div>
    <div style="text-indent: 36pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>. Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant to this Warrant shall be in writing
      and shall be conclusively deemed to have been duly given (i) when hand delivered to the other party; (ii) when sent by email or facsimile if sent between 8:00 a.m. and 5:00 p.m. recipient&#8217;s local time on a Business Day, or on the next Business Day if
      sent by email or facsimile other than between 8:00 a.m. and 5:00 p.m. recipient&#8217;s local time on a Business Day; (iii) seven Business Days after deposit in the U.S. mail with first class or certified mail receipt requested postage prepaid and
      addressed to the other party; or (iv) the next Business Day after deposit with an international overnight delivery service, postage prepaid, addressed to the parties with next Business Day delivery guaranteed, provided that the sending party receives
      a confirmation of delivery from the delivery service provider. Each person making a communication hereunder by email or facsimile shall promptly confirm by telephone between 8:00 a.m. and 5:00 p.m. recipient&#8217;s local time on a Business Day to the
      person to whom such communication was addressed each communication made by it by email or facsimile pursuant hereto but the absence of such confirmation shall not affect the validity of any such communication. All communications shall be sent to the
      address, email address or facsimile number of a party appearing in its signature block hereto or at such address, email address or facsimile number as such party may designate by ten (10) days advance written notice to the other parties hereto.</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Specific Performance</u>. Each party hereto acknowledges and agrees that any breach of this Warrant would result in substantial harm to the other party hereto for
      which monetary damages alone could not adequately compensate. Therefore, the parties hereto unconditionally and irrevocably agree that any non-breaching party hereto shall be entitled to seek protective orders, injunctive relief and other remedies
      available at law or in equity (including, without limitation, seeking specific performance).</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt; text-align: justify;">14.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>. This Warrant may be executed and delivered by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but
      all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.www.docusign.com) or
      other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-align: center;">[Remainder of Page Intentionally Left Blank]</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="font-size: 10pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer as of the Amended and Restated Date indicated above.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z1d718e3c3f004537b4d189dd8ab35554" style="width: 100%;">

        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt;" colspan="2">
            <div style="font-weight: bold;"><u>COMPANY</u>:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt;" colspan="2">
            <div style="font-weight: bold;">CELULARITY INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; font-size: 10pt; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 47%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;/s/ Robert J. Hariri</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Name: Robert J. Hariri</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Title: CEO</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt;" colspan="2">
            <div style="font-weight: bold;"><u>HOLDER</u>:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt;" colspan="2">
            <div style="font-weight: bold;">DRAGASAC LIMITED</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; font-size: 10pt; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 47%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Name:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Title:</div>
          </td>
        </tr>

    </table>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-style: italic;">Signature Page to Warrant &#8211; Dragasac Limited</font>]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="font-size: 10pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer as of the Date of Issuance indicated above.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8597ef5026c64d1da0dedf6ec71e6bd0" style="width: 100%;">

        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt;" colspan="2">
            <div style="font-weight: bold;"><u>COMPANY</u>:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt; font-weight: bold;" colspan="2">
            <div>CELULARITY INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; font-size: 10pt; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 47%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Name: Robert J. Hariri</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Title: CEO</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt;" colspan="2">
            <div style="font-weight: bold;"><u>HOLDER:</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="font-size: 10pt; font-weight: bold;" colspan="2">
            <div>DRAGASAC LIMITED</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; font-size: 10pt; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 47%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Tan Kong Han</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Name: Tan Kong Han</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; font-size: 10pt;">&#160;</td>
          <td style="width: 3%; font-size: 10pt;">&#160;</td>
          <td style="width: 47%; font-size: 10pt;">
            <div>Title: Director</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="font-size: 10pt;">
      <div style="text-align: center; font-family: 'Times New Roman';">[<font style="font-style: italic;">Signature Page to Warrant &#8211; Dragasac Limited</font>]</div>
      <div style="text-align: center; font-family: 'Times New Roman';"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>EXHIBIT A</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-variant: small-caps; font-weight: bold;">Notice of Exercise</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;">To:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Celularity Inc.</div>
    <div style="font-size: 10pt; margin-left: 36pt;">170 Park Ave</div>
    <div style="font-size: 10pt; margin-left: 36pt;">Florham Park, New Jersey 07932</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;">By checking the appropriate line, the undersigned (&#8220;Holder&#8221;), pursuant to the provisions set forth in the Amended and Restated Warrant to Purchase Class A Common Stock, dated January [______], 2025 (the &#8220;Warrant&#8221;), hereby
      elects to purchase 535,274 shares of Class A Common Stock (as defined in the Warrant) pursuant to the terms of the Warrant, and tenders herewith payment of the purchase price for such shares in full as follows:</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb13c336f96864ea69d66fa8f56030179" class="DSPFListTable" style="width: 100%;">

        <tr>
          <td style="width: 32.35pt; font-size: 10pt;">&#9744;</td>
          <td style="width: auto; font-size: 10pt;">
            <div>check in the amount of $<font style="font-family: 'Times New Roman';">_______________</font> <font style="font-family: 'Times New Roman';"></font>payable to order of the Company enclosed herewith</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z7e8a4073e27f49188eac4f24a5e25b7f" class="DSPFListTable" style="width: 100%;">

        <tr>
          <td style="width: 32.35pt; font-size: 10pt;">&#9744;</td>
          <td style="width: auto; font-size: 10pt;">
            <div>wire transfer of immediately available funds to the Company&#8217;s bank account</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zce0b2bbe2dc445c1ac4890a68f3bd6fc" class="DSPFListTable" style="width: 100%;">

        <tr>
          <td style="width: 32.35pt; font-size: 10pt;">&#9744;</td>
          <td style="width: auto; font-size: 10pt;">
            <div>cashless exercise pursuant to <u>Section 4.2</u> of the Warrant</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 23%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 52.36%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">
            <div>Date:</div>
          </td>
          <td style="width: 52.36%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 52.36%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 52.36%; vertical-align: top;">
            <div>DRAGASAC LIMITED, <u>TAN</u> KONG HAN (DIRECTOR)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" colspan="2">&#160;</td>
          <td style="width: 52.36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 52.36%; vertical-align: top;">
            <div>(Print Name)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 52.36%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" colspan="2">&#160;</td>
          <td style="width: 52.36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 52.36%; vertical-align: top;">
            <div>Signature</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;"> </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
